Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
Go back to Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance| Pfizer Inc. (NYSE: PFE) | Delayed: 28.30 -0.27 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.57 | 52 Week High | $37.39 | |||
| Open | $28.44 | 52 Week Low | $28.25 | |||
| Day High | $28.50 | P/E | 17.15 | |||
| Day Low | $28.15 | EPS | $1.65 | |||
| Volume | 34,599,455 | |||||
